Peripartum Neuraxial Analgesia May Not Be Associated With Postpartum MS Relapse
Peripartum neuraxial analgesia may not be associated with an increased risk for multiple sclerosis relapse.
Multiple Sclerosis
Cognitive Consequences Worse for Pediatric-Onset Multiple Sclerosis
Researchers compared long-term information-processing efficiency between patients with pediatric-onset MS and those with adult-onset MS in a longitudinal cohort study.
Dimethyl Fumarate Makes Lymphocyte Subset Monitoring Unnecessary in Multiple Sclerosis
Dimethyl fumarate induced changes in the multiple sclerosis lymphocyte repertoire, indicating that lymphocyte subset monitoring is not required for safety vigilance.
Model Explores How Statins Alter Multiple Sclerosis Outcomes
Simvastatin’s beneficial effects on clinical outcomes and brain atrophy in patients with multiple sclerosis (MS) are largely independent of cholesterol levels.
FDA to Review Ozanimod for Relapsing Forms of MS
The FDA has accepted for review the New Drug Application (NDA) for ozanimod (Celgene), an investigational treatment for relapsing forms of multiple sclerosis (MS).
Recommendations Developed for Pediatric Multiple Sclerosis Trials
The International Pediatric Multiple Sclerosis Study Group has updated standards for future clinical trials in pediatric multiple sclerosis.
Case Highlights How Symptoms of Cobalamin Deficiency Can Mimic MS
A recently published report describes the case of a 69-year-old female patient with cobalamin deficiency who was mistakenly diagnosed with primary progressive multiple sclerosis (PPMS).
Multiple Sclerosis Flowsheet Deemed Acceptable by Clinicians and Staff
Research shows the Multiple Sclerosis Flowsheet database has demonstrated acceptability among staff and clinicians.
Efficacy of ADS-5102 Extended Release for Impaired Walking in Multiple Sclerosis
The investigators of this Phase 3 study sought to evaluate the efficacy and safety of ADS-5102 (amantadine) extended-release capsules to treat multiple sclerosis patients with walking impairment.
Focused Healthcare Practitioner Discussion Improves MS Relapse Outcomes
Interactive discussions with healthcare practitioners (HCPs) and patient education regarding multiple sclerosis (MS) relapse increases the likelihood of patients reporting relapses and achieving more proactive disease management
Next post in CMSC 2019 Coverage
